SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-283822
Filing Date
2015-08-10
Accepted
2015-08-10 07:01:16
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d65681d10q.htm 10-Q 531146
2 EX-31.1 d65681dex311.htm EX-31.1 5962
3 EX-31.2 d65681dex312.htm EX-31.2 6006
4 EX-32.1 d65681dex321.htm EX-32.1 3388
5 EX-32.2 d65681dex322.htm EX-32.2 3428
  Complete submission text file 0001193125-15-283822.txt   2482983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT kpti-20150630.xml EX-101.INS 366477
7 XBRL TAXONOMY EXTENSION SCHEMA kpti-20150630.xsd EX-101.SCH 29753
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kpti-20150630_cal.xml EX-101.CAL 47690
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kpti-20150630_def.xml EX-101.DEF 85577
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20150630_lab.xml EX-101.LAB 264624
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20150630_pre.xml EX-101.PRE 172575
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36167 | Film No.: 151039160
SIC: 2834 Pharmaceutical Preparations